CRSP icon

CRISPR Therapeutics
CRSP

Overview Fund Activity

444 hedge funds and large institutions have $3.21B invested in CRISPR Therapeutics in 2024 Q2 according to their latest regulatory filings, with 49 funds opening new positions, 157 increasing their positions, 126 reducing their positions, and 75 closing their positions.

Holders
444
Holders Change
-36
Holders Change %
-7.5%
% of All Funds
6.46%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.07%
New
49
Increased
157
Reduced
126
Closed
75
Calls
$127M
Puts
$119M
Net Calls
+$7.93M
Net Calls Change
-$36.1M

Top Buyers

1
State Street
1
State Street
Massachusetts
$129M
2
UBS AM
2
UBS AM
Illinois
$37.5M
3
FCM
3
Farallon Capital Management
California
$28.6M
4
BlackRock
4
BlackRock
New York
$150M
5
TCM
5
Tang Capital Management
California
$17.1M

Top Sellers

1
ACA
1
Avoro Capital Advisors
New York
$0
2
Morgan Stanley
2
Morgan Stanley
New York
$32.3M
3
AIM
3
ARK Investment Management
Florida
$420M
4
Barclays
4
Barclays
United Kingdom
$3.54M
5
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$22.7M
Name Market Value Shares Shares
Change 		Shares
Change %
Capital International Investors
1
Capital International Investors
California
$425M 7,865,253 +28,179 +0.4%
AIM
2
ARK Investment Management
Florida
$420M 7,778,536 -378,492 -5%
Sumitomo Mitsui Trust Group
3
Sumitomo Mitsui Trust Group
Japan
$170M 3,151,514 -117,271 -4%
NAMA
4
Nikko Asset Management Americas
New York
$170M 3,151,514 -117,271 -4%
BlackRock
5
BlackRock
New York
$150M 2,777,784 +231,423 +9%
T. Rowe Price Investment Management
6
T. Rowe Price Investment Management
Maryland
$147M 2,730,652 +26,321 +1%
State Street
7
State Street
Massachusetts
$129M 2,393,684 +898,476 +60%
Fidelity Investments
8
Fidelity Investments
Massachusetts
$127M 2,353,091 +113,408 +5%
Vanguard Group
9
Vanguard Group
Pennsylvania
$94.4M 1,748,513 +111,714 +7%
NMC
10
NEA Management Company
Maryland
$85.8M 1,587,854 – –
EC
11
EcoR1 Capital
California
$75M 1,389,276 – –
SOCM
12
SR One Capital Management
Pennsylvania
$56.7M 1,048,951 – –
Loomis, Sayles & Company
13
Loomis, Sayles & Company
Massachusetts
$54.3M 1,006,213 -19,030 -2%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$52.6M 973,018 +63,720 +7%
Dimensional Fund Advisors
15
Dimensional Fund Advisors
Texas
$51.3M 950,149 +19,094 +2%
Bank of America
16
Bank of America
North Carolina
$50.9M 941,550 +78,336 +9%
Charles Schwab
17
Charles Schwab
California
$38.8M 717,606 +48,414 +7%
UBS AM
18
UBS AM
Illinois
$37.5M 693,958 +583,493 +528%
CIM
19
Contrarius Investment Management
Jersey
$37M 685,716 +19,716 +3%
Norges Bank
20
Norges Bank
Norway
$35.1M 650,208 +59,940 +10%
BG
21
Bellevue Group
Switzerland
$33.4M 617,649 -2,301 -0.4%
Morgan Stanley
22
Morgan Stanley
New York
$32.3M 597,679 -488,245 -45%
FCM
23
Farallon Capital Management
California
$28.6M 530,000 +530,000 New
VVM
24
Versant Venture Management
California
$26.9M 498,558 – –
Federated Hermes
25
Federated Hermes
Pennsylvania
$24.2M 447,606 – –
1
2 3 4 5